Mount Elbrus Russia. The name "Elbrus" is a metathesis of "Alborz", which is also the name of a long mountain range in northern Iran. It is derived from Avestan "Harā Bərəzaitī", which is a legendary mountain in Iranian mythology. "Harā Bərəzaitī" reflects Proto-Iranian *"Harā Bṛzatī", which was reformed into Middle Persian as "Harborz", and into Modern Persian as "Alborz". "Bṛzatī" is the feminine form of the adjective *"bṛzant" ("high"), the reconstructed ancestor of Modern Ossetian "bærzond" ("high", "peak"), Modern Persian "barz" ("high"), "berāzande" ("elegant"), and "boland" ("high", "tall"), and Modern Kurdish "barz" ("high"). "Harā" may be interpreted as "watch" or "guard", from
MT-45 States the DEA placed MT-45 in Schedule 1 of the Controlled Substance Act. This took effect January 12, 2018. MT-45 MT-45 (IC-6) is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-(1,2-diphenylethyl)piperazine derivative, which is structurally unrelated to most other opioid drugs. Racemic MT-45 has around 80% the potency of morphine, with almost all opioid activity residing in the (S) enantiomer (the opposite stereochemistry from the related drug lefetamine). It has been used as a lead compound from which a large family of potent opioid drugs have been developed, including full agonists,